Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development.
暂无分享，去创建一个
A. Hassell | R. Gampe | J. Axten | S. P. Romeril | A. Shu | Jeffrey M. Ralph | J. R. Medina | Yanhong Feng | W. H. Li | Seth W. Grant | D. Heerding | E. Minthorn | T. Mencken | Nathan Gaul | A. Goetz | T. Stanley | C. Atkins | Rakesh Kumar | J. Medina | W. Li